0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IVD Antibodies Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-0D6223
Home | Market Reports | Health| Medical Facilities & Services
Global IVD Antibodies Market Insights Forecast to 2028
BUY CHAPTERS

Global IVD Antibodies Market Insights, Forecast to 2030

Code: QYRE-Auto-0D6223
Report
December 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

IVD Antibodies Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

IVD Antibodies Market

IVD Antibodies Market

In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.
Market Analysis and Insights: Global IVD Antibodies Market
The global IVD Antibodies market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for IVD Antibodies market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of IVD Antibodies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for IVD Antibodies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the IVD Antibodies revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global IVD Antibodies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for IVD Antibodies revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of IVD Antibodies Market Report

Report Metric Details
Report Name IVD Antibodies Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abcam, Thermo Fisher Scientific, Rockland Immunochemicals, GenScript, Bio-Rad Laboratories, SDIX, MEDICAL & BIOLOGICAL LABORATORIES, HyTest, Abbott
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of IVD Antibodies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of IVD Antibodies companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IVD Antibodies revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the IVD Antibodies Market report?

Ans: The main players in the IVD Antibodies Market are Abcam, Thermo Fisher Scientific, Rockland Immunochemicals, GenScript, Bio-Rad Laboratories, SDIX, MEDICAL & BIOLOGICAL LABORATORIES, HyTest, Abbott

What are the Application segmentation covered in the IVD Antibodies Market report?

Ans: The Applications covered in the IVD Antibodies Market report are Hospital, Specialty Clinic, Diagnostic Center, Others

What are the Type segmentation covered in the IVD Antibodies Market report?

Ans: The Types covered in the IVD Antibodies Market report are Cardiac Markers, Tumor Markers, Kidney Injury Markers

Recommended Reports

Diagnostics & IVD

Antibody Therapies

Specialized Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Antibodies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Cardiac Markers
1.2.3 Tumor Markers
1.2.4 Kidney Injury Markers
1.3 Market by Application
1.3.1 Global IVD Antibodies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Diagnostic Center
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVD Antibodies Market Perspective (2019-2030)
2.2 Global IVD Antibodies Growth Trends by Region
2.2.1 IVD Antibodies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 IVD Antibodies Historic Market Size by Region (2019-2024)
2.2.3 IVD Antibodies Forecasted Market Size by Region (2025-2030)
2.3 IVD Antibodies Market Dynamics
2.3.1 IVD Antibodies Industry Trends
2.3.2 IVD Antibodies Market Drivers
2.3.3 IVD Antibodies Market Challenges
2.3.4 IVD Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue IVD Antibodies by Players
3.1.1 Global IVD Antibodies Revenue by Players (2019-2024)
3.1.2 Global IVD Antibodies Revenue Market Share by Players (2019-2024)
3.2 Global IVD Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of IVD Antibodies, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global IVD Antibodies Market Concentration Ratio
3.4.1 Global IVD Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Antibodies Revenue in 2023
3.5 Global Key Players of IVD Antibodies Head office and Area Served
3.6 Global Key Players of IVD Antibodies, Product and Application
3.7 Global Key Players of IVD Antibodies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Antibodies Breakdown Data by Type
4.1 Global IVD Antibodies Historic Market Size by Type (2019-2024)
4.2 Global IVD Antibodies Forecasted Market Size by Type (2025-2030)
5 IVD Antibodies Breakdown Data by Application
5.1 Global IVD Antibodies Historic Market Size by Application (2019-2024)
5.2 Global IVD Antibodies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America IVD Antibodies Market Size (2019-2030)
6.2 North America IVD Antibodies Market Size by Type
6.2.1 North America IVD Antibodies Market Size by Type (2019-2024)
6.2.2 North America IVD Antibodies Market Size by Type (2025-2030)
6.2.3 North America IVD Antibodies Market Share by Type (2019-2030)
6.3 North America IVD Antibodies Market Size by Application
6.3.1 North America IVD Antibodies Market Size by Application (2019-2024)
6.3.2 North America IVD Antibodies Market Size by Application (2025-2030)
6.3.3 North America IVD Antibodies Market Share by Application (2019-2030)
6.4 North America IVD Antibodies Market Size by Country
6.4.1 North America IVD Antibodies Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America IVD Antibodies Market Size by Country (2019-2024)
6.4.3 North America IVD Antibodies Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe IVD Antibodies Market Size (2019-2030)
7.2 Europe IVD Antibodies Market Size by Type
7.2.1 Europe IVD Antibodies Market Size by Type (2019-2024)
7.2.2 Europe IVD Antibodies Market Size by Type (2025-2030)
7.2.3 Europe IVD Antibodies Market Share by Type (2019-2030)
7.3 Europe IVD Antibodies Market Size by Application
7.3.1 Europe IVD Antibodies Market Size by Application (2019-2024)
7.3.2 Europe IVD Antibodies Market Size by Application (2025-2030)
7.3.3 Europe IVD Antibodies Market Share by Application (2019-2030)
7.4 Europe IVD Antibodies Market Size by Country
7.4.1 Europe IVD Antibodies Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe IVD Antibodies Market Size by Country (2019-2024)
7.4.3 Europe IVD Antibodies Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China IVD Antibodies Market Size (2019-2030)
8.2 China IVD Antibodies Market Size by Type
8.2.1 China IVD Antibodies Market Size by Type (2019-2024)
8.2.2 China IVD Antibodies Market Size by Type (2025-2030)
8.2.3 China IVD Antibodies Market Share by Type (2019-2030)
8.3 China IVD Antibodies Market Size by Application
8.3.1 China IVD Antibodies Market Size by Application (2019-2024)
8.3.2 China IVD Antibodies Market Size by Application (2025-2030)
8.3.3 China IVD Antibodies Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia IVD Antibodies Market Size (2019-2030)
9.2 Asia IVD Antibodies Market Size by Type
9.2.1 Asia IVD Antibodies Market Size by Type (2019-2024)
9.2.2 Asia IVD Antibodies Market Size by Type (2025-2030)
9.2.3 Asia IVD Antibodies Market Share by Type (2019-2030)
9.3 Asia IVD Antibodies Market Size by Application
9.3.1 Asia IVD Antibodies Market Size by Application (2019-2024)
9.3.2 Asia IVD Antibodies Market Size by Application (2025-2030)
9.3.3 Asia IVD Antibodies Market Share by Application (2019-2030)
9.4 Asia IVD Antibodies Market Size by Region
9.4.1 Asia IVD Antibodies Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia IVD Antibodies Market Size by Region (2019-2024)
9.4.3 Asia IVD Antibodies Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America IVD Antibodies Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America IVD Antibodies Market Size by Type
10.2.1 Middle East, Africa, and Latin America IVD Antibodies Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America IVD Antibodies Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America IVD Antibodies Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America IVD Antibodies Market Size by Application
10.3.1 Middle East, Africa, and Latin America IVD Antibodies Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America IVD Antibodies Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America IVD Antibodies Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America IVD Antibodies Market Size by Country
10.4.1 Middle East, Africa, and Latin America IVD Antibodies Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America IVD Antibodies Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America IVD Antibodies Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam IVD Antibodies Introduction
11.1.4 Abcam Revenue in IVD Antibodies Business (2019-2024)
11.1.5 Abcam Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific IVD Antibodies Introduction
11.2.4 Thermo Fisher Scientific Revenue in IVD Antibodies Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Rockland Immunochemicals
11.3.1 Rockland Immunochemicals Company Details
11.3.2 Rockland Immunochemicals Business Overview
11.3.3 Rockland Immunochemicals IVD Antibodies Introduction
11.3.4 Rockland Immunochemicals Revenue in IVD Antibodies Business (2019-2024)
11.3.5 Rockland Immunochemicals Recent Developments
11.4 GenScript
11.4.1 GenScript Company Details
11.4.2 GenScript Business Overview
11.4.3 GenScript IVD Antibodies Introduction
11.4.4 GenScript Revenue in IVD Antibodies Business (2019-2024)
11.4.5 GenScript Recent Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories IVD Antibodies Introduction
11.5.4 Bio-Rad Laboratories Revenue in IVD Antibodies Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Developments
11.6 SDIX
11.6.1 SDIX Company Details
11.6.2 SDIX Business Overview
11.6.3 SDIX IVD Antibodies Introduction
11.6.4 SDIX Revenue in IVD Antibodies Business (2019-2024)
11.6.5 SDIX Recent Developments
11.7 MEDICAL & BIOLOGICAL LABORATORIES
11.7.1 MEDICAL & BIOLOGICAL LABORATORIES Company Details
11.7.2 MEDICAL & BIOLOGICAL LABORATORIES Business Overview
11.7.3 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Introduction
11.7.4 MEDICAL & BIOLOGICAL LABORATORIES Revenue in IVD Antibodies Business (2019-2024)
11.7.5 MEDICAL & BIOLOGICAL LABORATORIES Recent Developments
11.8 HyTest
11.8.1 HyTest Company Details
11.8.2 HyTest Business Overview
11.8.3 HyTest IVD Antibodies Introduction
11.8.4 HyTest Revenue in IVD Antibodies Business (2019-2024)
11.8.5 HyTest Recent Developments
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott IVD Antibodies Introduction
11.9.4 Abbott Revenue in IVD Antibodies Business (2019-2024)
11.9.5 Abbott Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global IVD Antibodies Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Cardiac Markers
    Table 3. Key Players of Tumor Markers
    Table 4. Key Players of Kidney Injury Markers
    Table 5. Global IVD Antibodies Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global IVD Antibodies Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global IVD Antibodies Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global IVD Antibodies Market Share by Region (2019-2024)
    Table 9. Global IVD Antibodies Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global IVD Antibodies Market Share by Region (2025-2030)
    Table 11. IVD Antibodies Market Trends
    Table 12. IVD Antibodies Market Drivers
    Table 13. IVD Antibodies Market Challenges
    Table 14. IVD Antibodies Market Restraints
    Table 15. Global IVD Antibodies Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global IVD Antibodies Revenue Share by Players (2019-2024)
    Table 17. Global Top IVD Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Antibodies as of 2023)
    Table 18. Global IVD Antibodies Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by IVD Antibodies Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of IVD Antibodies, Headquarters and Area Served
    Table 21. Global Key Players of IVD Antibodies, Product and Application
    Table 22. Global Key Players of IVD Antibodies, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global IVD Antibodies Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global IVD Antibodies Revenue Market Share by Type (2019-2024)
    Table 26. Global IVD Antibodies Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global IVD Antibodies Revenue Market Share by Type (2025-2030)
    Table 28. Global IVD Antibodies Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global IVD Antibodies Revenue Share by Application (2019-2024)
    Table 30. Global IVD Antibodies Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global IVD Antibodies Revenue Share by Application (2025-2030)
    Table 32. North America IVD Antibodies Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America IVD Antibodies Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America IVD Antibodies Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America IVD Antibodies Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America IVD Antibodies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America IVD Antibodies Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America IVD Antibodies Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe IVD Antibodies Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe IVD Antibodies Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe IVD Antibodies Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe IVD Antibodies Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe IVD Antibodies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe IVD Antibodies Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe IVD Antibodies Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China IVD Antibodies Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China IVD Antibodies Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China IVD Antibodies Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China IVD Antibodies Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia IVD Antibodies Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia IVD Antibodies Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia IVD Antibodies Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia IVD Antibodies Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia IVD Antibodies Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia IVD Antibodies Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia IVD Antibodies Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America IVD Antibodies Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America IVD Antibodies Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America IVD Antibodies Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America IVD Antibodies Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America IVD Antibodies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America IVD Antibodies Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America IVD Antibodies Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Abcam Company Details
    Table 65. Abcam Business Overview
    Table 66. Abcam IVD Antibodies Product
    Table 67. Abcam Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
    Table 68. Abcam Recent Developments
    Table 69. Thermo Fisher Scientific Company Details
    Table 70. Thermo Fisher Scientific Business Overview
    Table 71. Thermo Fisher Scientific IVD Antibodies Product
    Table 72. Thermo Fisher Scientific Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
    Table 73. Thermo Fisher Scientific Recent Developments
    Table 74. Rockland Immunochemicals Company Details
    Table 75. Rockland Immunochemicals Business Overview
    Table 76. Rockland Immunochemicals IVD Antibodies Product
    Table 77. Rockland Immunochemicals Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
    Table 78. Rockland Immunochemicals Recent Developments
    Table 79. GenScript Company Details
    Table 80. GenScript Business Overview
    Table 81. GenScript IVD Antibodies Product
    Table 82. GenScript Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
    Table 83. GenScript Recent Developments
    Table 84. Bio-Rad Laboratories Company Details
    Table 85. Bio-Rad Laboratories Business Overview
    Table 86. Bio-Rad Laboratories IVD Antibodies Product
    Table 87. Bio-Rad Laboratories Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
    Table 88. Bio-Rad Laboratories Recent Developments
    Table 89. SDIX Company Details
    Table 90. SDIX Business Overview
    Table 91. SDIX IVD Antibodies Product
    Table 92. SDIX Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
    Table 93. SDIX Recent Developments
    Table 94. MEDICAL & BIOLOGICAL LABORATORIES Company Details
    Table 95. MEDICAL & BIOLOGICAL LABORATORIES Business Overview
    Table 96. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Product
    Table 97. MEDICAL & BIOLOGICAL LABORATORIES Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
    Table 98. MEDICAL & BIOLOGICAL LABORATORIES Recent Developments
    Table 99. HyTest Company Details
    Table 100. HyTest Business Overview
    Table 101. HyTest IVD Antibodies Product
    Table 102. HyTest Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
    Table 103. HyTest Recent Developments
    Table 104. Abbott Company Details
    Table 105. Abbott Business Overview
    Table 106. Abbott IVD Antibodies Product
    Table 107. Abbott Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
    Table 108. Abbott Recent Developments
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global IVD Antibodies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global IVD Antibodies Market Share by Type: 2023 VS 2030
    Figure 3. Cardiac Markers Features
    Figure 4. Tumor Markers Features
    Figure 5. Kidney Injury Markers Features
    Figure 6. Global IVD Antibodies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global IVD Antibodies Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Case Studies
    Figure 9. Specialty Clinic Case Studies
    Figure 10. Diagnostic Center Case Studies
    Figure 11. Others Case Studies
    Figure 12. IVD Antibodies Report Years Considered
    Figure 13. Global IVD Antibodies Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global IVD Antibodies Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global IVD Antibodies Market Share by Region: 2023 VS 2030
    Figure 16. Global IVD Antibodies Market Share by Players in 2023
    Figure 17. Global Top IVD Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Antibodies as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by IVD Antibodies Revenue in 2023
    Figure 19. North America IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America IVD Antibodies Market Share by Type (2019-2030)
    Figure 21. North America IVD Antibodies Market Share by Application (2019-2030)
    Figure 22. North America IVD Antibodies Market Share by Country (2019-2030)
    Figure 23. United States IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe IVD Antibodies Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe IVD Antibodies Market Share by Type (2019-2030)
    Figure 27. Europe IVD Antibodies Market Share by Application (2019-2030)
    Figure 28. Europe IVD Antibodies Market Share by Country (2019-2030)
    Figure 29. Germany IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China IVD Antibodies Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China IVD Antibodies Market Share by Type (2019-2030)
    Figure 37. China IVD Antibodies Market Share by Application (2019-2030)
    Figure 38. Asia IVD Antibodies Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia IVD Antibodies Market Share by Type (2019-2030)
    Figure 40. Asia IVD Antibodies Market Share by Application (2019-2030)
    Figure 41. Asia IVD Antibodies Market Share by Region (2019-2030)
    Figure 42. Japan IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America IVD Antibodies Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America IVD Antibodies Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America IVD Antibodies Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America IVD Antibodies Market Share by Country (2019-2030)
    Figure 52. Brazil IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Abcam Revenue Growth Rate in IVD Antibodies Business (2019-2024)
    Figure 59. Thermo Fisher Scientific Revenue Growth Rate in IVD Antibodies Business (2019-2024)
    Figure 60. Rockland Immunochemicals Revenue Growth Rate in IVD Antibodies Business (2019-2024)
    Figure 61. GenScript Revenue Growth Rate in IVD Antibodies Business (2019-2024)
    Figure 62. Bio-Rad Laboratories Revenue Growth Rate in IVD Antibodies Business (2019-2024)
    Figure 63. SDIX Revenue Growth Rate in IVD Antibodies Business (2019-2024)
    Figure 64. MEDICAL & BIOLOGICAL LABORATORIES Revenue Growth Rate in IVD Antibodies Business (2019-2024)
    Figure 65. HyTest Revenue Growth Rate in IVD Antibodies Business (2019-2024)
    Figure 66. Abbott Revenue Growth Rate in IVD Antibodies Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Spinal Needle for Surgery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37D12504
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Kidney Disease Management Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30D17962
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Renal Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39G18133
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI-powered Care Coordination Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4N20277
Fri Nov 28 00:00:00 UTC 2025

Add to Cart